ArticleOncoimmunology2021

VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma.

Hai-Xia He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.